These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 30267220)
1. Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers. Olbrich KJ; Müller D; Schumacher S; Beck E; Meszaros K; Koerber F Infect Dis Ther; 2018 Dec; 7(4):421-438. PubMed ID: 30267220 [TBL] [Abstract][Full Text] [Related]
2. The Health Burden of Invasive Meningococcal Disease: A Systematic Review. Strifler L; Morris SK; Dang V; Tu HA; Minhas RS; Jamieson FB; Deeks SL; Crowcroft NS; Sander B J Pediatric Infect Dis Soc; 2016 Dec; 5(4):417-430. PubMed ID: 26501470 [TBL] [Abstract][Full Text] [Related]
3. Understanding the Sequelae of Invasive Meningococcal Disease in the United States. Marshall GS; McCormick ZL; Johns JS; Verduzco-Gutierrez M; Herrera-Restrepo O; Harrison LH Infect Dis Ther; 2024 Nov; 13(11):2213-2220. PubMed ID: 39269567 [TBL] [Abstract][Full Text] [Related]
4. Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review. Shen J; Begum N; Ruiz-Garcia Y; Martinon-Torres F; Bekkat-Berkani R; Meszaros K BMC Public Health; 2022 May; 22(1):1078. PubMed ID: 35641955 [TBL] [Abstract][Full Text] [Related]
5. Risk of sequelae after invasive meningococcal disease. Voss SS; Nielsen J; Valentiner-Branth P BMC Infect Dis; 2022 Feb; 22(1):148. PubMed ID: 35148717 [TBL] [Abstract][Full Text] [Related]
6. A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease. Marten O; Koerber F; Bloom D; Bullinger M; Buysse C; Christensen H; De Wals P; Dohna-Schwake C; Henneke P; Kirchner M; Knuf M; Lawrenz B; Monteiro AL; Sevilla JP; Van de Velde N; Welte R; Wright C; Greiner W Health Qual Life Outcomes; 2019 May; 17(1):87. PubMed ID: 31118091 [TBL] [Abstract][Full Text] [Related]
7. Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach. Zeevat F; Simons JJM; Westra TA; Wilschut JC; van Sorge NM; Boersma C; Postma MJ Infect Dis Ther; 2024 Mar; 13(3):481-499. PubMed ID: 38366286 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of invasive meningococcal disease and its sequelae: a population-based study in Italian primary care, 2000-2019. Lapi F; Marconi E; Vetrano DL; Rossi A; Lagolio E; Baldo V; Cricelli C Fam Pract; 2023 Jun; ():. PubMed ID: 37262015 [TBL] [Abstract][Full Text] [Related]
9. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children. Wang B; Haji Ali Afzali H; Marshall H Vaccine; 2014 Aug; 32(37):4791-8. PubMed ID: 24998605 [TBL] [Abstract][Full Text] [Related]
10. Follow-up care experience of patients with invasive meningococcal disease and their family caregivers: a qualitative study. Baloche A; Bedouch P; Carrouel F; Argaud L; Kolev K; Mortamet G; Schwebel C; Mick G; Dussart C BMC Infect Dis; 2024 Sep; 24(1):1002. PubMed ID: 39300360 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM). Shen J; Bouée S; Aris E; Emery C; Beck EC Infect Dis Ther; 2022 Feb; 11(1):249-262. PubMed ID: 34791633 [TBL] [Abstract][Full Text] [Related]
12. AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults. Marshall H; McMillan M; Wang B; Booy R; Afzali H; Buttery J; Blyth CC; Richmond P; Shaw D; Gordon D; Barton B BMJ Open; 2019 Dec; 9(12):e032583. PubMed ID: 31888931 [TBL] [Abstract][Full Text] [Related]
13. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany. Scholz S; Koerber F; Meszaros K; Fassbender RM; Ultsch B; Welte RR; Greiner W Vaccine; 2019 Mar; 37(12):1692-1701. PubMed ID: 30661834 [TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients. Ingen-Housz-Oro S; Alves A; Colin A; Ouedraogo R; Layese R; Canoui-Poitrine F; Chosidow O; Mekontso-Dessap A; Wolkenstein P; de Prost N Br J Dermatol; 2020 Apr; 182(4):916-926. PubMed ID: 31385287 [TBL] [Abstract][Full Text] [Related]
15. Long-term impact of invasive meningococcal disease in children: SEINE study protocol. Baloche A; Jung C; Levy M; Elbez-Rubinstein A; Béchet S; Layouni I; Monguillot G; Taha MK; Cohen R; Levy C PLoS One; 2022; 17(5):e0268536. PubMed ID: 35617288 [TBL] [Abstract][Full Text] [Related]
16. The burden and impact of severe and long-term sequelae of meningococcal disease. Vyse A; Anonychuk A; Jäkel A; Wieffer H; Nadel S Expert Rev Anti Infect Ther; 2013 Jun; 11(6):597-604. PubMed ID: 23750731 [TBL] [Abstract][Full Text] [Related]
17. Meningococcal disease in childhood: epidemiology, clinical features and prevention. Bosis S; Mayer A; Esposito S J Prev Med Hyg; 2015 Aug; 56(3):E121-4. PubMed ID: 26788732 [TBL] [Abstract][Full Text] [Related]
18. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Weil-Olivier C; Taha MK; Bouée S; Emery C; Loncle-Provot V; Nachbaur G; Beck E; Pribil C Hum Vaccin Immunother; 2022 Dec; 18(1):2021764. PubMed ID: 35192785 [TBL] [Abstract][Full Text] [Related]